Literature DB >> 10806562

Risk factors for venous thromboembolism following prolonged air travel. Coach class thrombosis.

B Arfvidsson1, B Eklof, R L Kistner, E M Masuda, D T Sato.   

Abstract

Venous thromboembolism (VTE) in legs and lungs is a potentially life-threatening condition. The incidence of VTE associated with air travel is still unknown, but it may have increased. Most travelers who develop symptoms do so within 24 hours after their flight takes off. Predisposing risk factors may be divided into patient-related and cabin-related factors, both of which are described. It is emphasized that better information and better inflight precautions can minimize these risk factors.

Entities:  

Mesh:

Year:  2000        PMID: 10806562     DOI: 10.1016/s0889-8588(05)70140-4

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  5 in total

1.  The weak connection between venous thromboembolism and air travel.

Authors:  E Weir
Journal:  CMAJ       Date:  2001-04-03       Impact factor: 8.262

2.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  Airline chair-rest deconditioning: induction of immobilisation thromboemboli?

Authors:  John E Greenleaf; Nancy J Rehrer; Stanley R Mohler; David T Quach; David G Evans
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

4.  Deep venous thrombosis of the lower limb in young ambulant ghanaians.

Authors:  Hk Aduful; R Darko
Journal:  Ghana Med J       Date:  2007-03

5.  The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance travelers.

Authors:  Fahad M Al-Hameed; Hasan M Al-Dorzi; Mohamed A Abdelaal; Ali Alaklabi; Ebtisam Bakhsh; Yousef A Alomi; Mohammad Al Baik; Salah Aldahan; Holger Schünemann; Jan Brozek; Wojtek Wiercioch; Andrea J Darzi; Reem Waziry; Elie A Akl
Journal:  Saudi Med J       Date:  2017-01       Impact factor: 1.484

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.